Terms: = Lung cancer AND PBRM1, BAF180, 55193, PB1, MGC156156, MGC156155 AND Prognosis
7 results:
1. Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma.
de Miguel-Perez D; Pickering EM; Malapelle U; Grier W; Pepe F; Pisapia P; Russo G; Pinto JA; Russo A; Troncone G; Culligan MJ; Scilla KA; Mehra R; Mohindra P; Arrieta O; Cardona AF; Del Re M; Sachdeva A; Hirsch FR; Wolf A; Friedberg JS; Rolfo C
Eur J Cancer; 2024 Jan; 196():113457. PubMed ID: 38008032
[TBL] [Abstract] [Full Text] [Related]
2. Molecular alterations and potential actionable mutations in peritoneal mesothelioma: a scoping review of high-throughput sequencing studies.
Dietz MV; van Kooten JP; Paats MS; Aerts JGVJ; Verhoef C; Madsen EVE; Dubbink HJ; von der Thüsen JH
ESMO Open; 2023 Aug; 8(4):101600. PubMed ID: 37453150
[TBL] [Abstract] [Full Text] [Related]
3. Dysregulation of SWI/SNF Chromatin Remodelers in NSCLC: Its Influence on cancer Therapies including Immunotherapy.
Shi Y; Shin DS
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371564
[TBL] [Abstract] [Full Text] [Related]
4. Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure.
Lin Z; Huang L; Li S; Gu J; Cui X; Zhou Y
Sci Rep; 2020 Dec; 10(1):21530. PubMed ID: 33299035
[TBL] [Abstract] [Full Text] [Related]
5. Integrative genomic analysis of peritoneal malignant mesothelioma: understanding a case with extraordinary chemotherapy response.
Lund-Andersen C; Nakken S; Nygård S; Fromm B; Aasheim LB; Davidson B; Julsrud L; Abrahamsen TW; Kristensen AT; Dybdahl B; Larsen SG; Hovig E; Flatmark K
Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30862609
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic role of BAP-1 and PBRM-1 expression in intrahepatic cholangiocarcinoma.
Sarcognato S; Gringeri E; Fassan M; Di Giunta M; Maffeis V; Guzzardo V; Cillo U; Guido M
Virchows Arch; 2019 Jan; 474(1):29-37. PubMed ID: 30377796
[TBL] [Abstract] [Full Text] [Related]
7. Loss of BAP1 protein expression in the first metastatic site predicts prognosis in patients with clear cell renal cell carcinoma.
Miura Y; Inoshita N; Ikeda M; Miyama Y; Oki R; Oka S; Kondoh C; Ozaki Y; Tanabe Y; Kurosawa K; Urakami S; Kohno T; Okaneya T; Takano T
Urol Oncol; 2017 Jun; 35(6):386-391. PubMed ID: 28284891
[TBL] [Abstract] [Full Text] [Related]
